Although change may be intimidating, disruptive innovation allows manufacturers to achieve increased efficiency and quality. Several drivers affect how the appropriate facility design and unit operations for a process are selected, making it imperative to properly evaluate each option.
The performance of two assays for determination of adenovirus concentration based on surface plasmon resonance (SPR) is demonstrated in this application note.
Here, we describe the development of two effective downstream processes for purification of adenovirus from cell culture harvest.
Here we describe screening of detergents for release of adenovirus from HEK293 host cells to replace the traditionally used detergent Triton™.
This application note describes the production of adenovirus in HEK293 cells cultured in HyClone™ CDM4HEK293 culture medium.
Cell therapy manufacturing has been a complex, challenging and costly process, but a new manufacturing solution seeks to change that
Digitally enabled cryogenic cold chain technology can now deliver the raw materials needed to manufacture cellular therapies
Reproducible freezing and thawing is critical for successful cell therapies. GE Healthcare’s G. John Morris explains why.
Insights on cell therapy manufacturing challenges and how to overcome them.
After the approvals of several cell and gene therapies the new question is "How can we make them better?".